Celltrion
068270.KS
#778
Rank
NZ$54.60 B
Marketcap
NZ$249.61
Share price
-4.30%
Change (1 day)
16.53%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.30. In 2023 the company made an earnings per share (EPS) of NZ$4.82 a decrease over its 2022 EPS that were of NZ$4.92.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.22
2023NZ$4.82-2.08%
2022NZ$4.92-11.72%
2021NZ$5.582.03%
2020NZ$5.4682.8%
2019NZ$2.9918.31%
2018NZ$2.53-36.33%
2017NZ$3.97161.25%
2016NZ$1.522.86%
2015NZ$1.4817.84%
2014NZ$1.255.87%
2013NZ$1.18-70.85%
2012NZ$4.06134.09%
2011NZ$1.7343.59%
2010NZ$1.2174.49%
2009NZ$0.69317.8%
2008NZ$0.17-71.7%
2007NZ$0.59